@entity739 and its related XXXX .

@entity1 @entity1032 @entity1625 @entity410 @entity739 @entity2473 @entity302 @entity6191
The purpose of this project was to study the relationship between @entity739 ( @entity739 ) and its related @entity302 , and reconsider the nosological limits of @entity739 . The electroclinical features of 45 @entity1 who experienced @entity2473 in series were investigated, as well as some features not common in @entity1 with @entity739 . All @entity1 were @entity1032 . The @entity1 were divided into three groups: Group 1 consisted of 12 @entity1 with @entity302 with onset in early infancy, group 2 consisted of 5 @entity1 with symptomatic @entity1625 associated with @entity2473 in series, and group 3 consisted of 28 @entity1 with @entity6191 who had @entity2473 in series after age 2 years. Partial @entity410 were the dominant symptom throughout the clinical course and @entity2473 in series associated with atypical @entity739 appeared transiently during infancy in a significant number of the @entity1 in group 1. In group 2, @entity410 ( @entity410 ) were the main @entity410 type and @entity739 was not observed during the clinical course. The EEGs in group 3 @entity1 showed diffuse slow spike-waves or multifocal @entity302 discharges in all but 1 @entity1 . The EEG of the remaining @entity1 still showed @entity739 at age 8 years. Therefore, group 1 @entity1 should be classified as having @entity739 although cortical mechanisms play a critical role in the occurrence of their @entity410 . Group 2 @entity1 should be considered as having a type of localization-related @entity302 even though they share a similar pathophysiological mechanism with group 1. In group 3, 1 @entity1 whose EEG still showed @entity739 was classified as having @entity739 . The other @entity1 should be classified as having @entity6191 other than @entity739 .
